Sinotau Pharmaceutical Group
Latest round
- Series E
Last raised
- Jul 2023
Total raised
- $292M
Investors
- 30
About Sinotau Pharmaceutical Group
Established in 2005 and based in Beijing, China, Sinotau Pharmaceutical Group operates as a biopharmaceutical company that provides targeted therapy and precision diagnostic radiopharmaceuticals. The company has molecular imaging bases in Jiangsu, Guangdong and Sichuan. It cooperates with over 300 hospitals, such as Biogen, Merck and abbvie, and the academic outreach team has more than 100 members. In 2017, the company established Jiangsu and Guangdong Branch. In December 2021, it obtained a radiation safety license and established Shanghai R&D Center. and CCT Fund Management, etc. The company's product pipelines are divided into two series, which include the radiopharmaceuticals field and the biopharmaceuticals field. The radiopharmaceuticals field focuses on the development of antibody biologics, and can treat patients with tumors, neurodegenerative diseases and autoimmune diseases. The species of the biopharmaceuticals field involved in 18F, 13C and 14C series nuclides. In addition, the company engages in academic promotion through various ways, including public numbers (Hexing Liaowang), literature publication, journal submission, expert collaboration, academic seminar salon, summit forum and clinical trial data interpretation.
Who invested in Sinotau Pharmaceutical Group
30 investors across 4 rounds
See all investors in Sinotau Pharmaceutical Group
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Sinotau Pharmaceutical Group
Who invested in Sinotau Pharmaceutical Group?
Sinotau Pharmaceutical Group has 30 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Sinotau Pharmaceutical Group raised?
Sinotau Pharmaceutical Group has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Sinotau Pharmaceutical Group last raise money?
Sinotau Pharmaceutical Group's most recent round on record is a Series E, in Jul 2023.
What does Sinotau Pharmaceutical Group do?
Established in 2005 and based in Beijing, China, Sinotau Pharmaceutical Group operates as a biopharmaceutical company that provides targeted therapy and precision diagnostic radiopharmaceuticals.
Where is Sinotau Pharmaceutical Group headquartered?
Sinotau Pharmaceutical Group is headquartered in Beijing, China.
Which VCs invest in companies like Sinotau Pharmaceutical Group?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Sinotau Pharmaceutical Group's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series E
Raising like Sinotau Pharmaceutical Group? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.